Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A.
about
Learning from myocarditis: mimicry, chaos and black holesEosinophils in Autoimmune Diseases.Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration.P2×7 purinergic signaling in dilated cardiomyopathy induced by auto-immunity against muscarinic M2 receptors: autoantibody levels, heart functionality and cytokine expression.Cardiac myosin-Th17 responses promote heart failure in human myocarditis.Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation.Complexities in the relationship between infection and autoimmunity.Determinants of eosinophil survival and apoptotic cell death.Regulation of autoimmune myocarditis by host responses to the microbiome.Natural killer cells in inflammatory heart disease.Cardiac Autoimmunity: Myocarditis.Collaborative Interferon-γ and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureusEosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy.Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart.Absence of nonhematopoietic MHC class II expression protects mice from experimental autoimmune myocarditis.Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy.The Contribution of Autoantibodies to Inflammatory Cardiovascular Pathology.Viral myocarditis
P2860
Q26992048-1F68D35D-CFEF-43C6-A527-878CD32A495DQ33607031-6B9AC260-B2D9-4205-9225-9C00C35CCF33Q35143773-259C4779-FA85-4172-9B5E-544629D4F2D8Q36305471-9B3EEA20-694E-4222-97C4-ED3E1512F699Q37046916-8A107F5C-6046-41E2-8DCF-78D3DB5A2DE8Q37217043-125AFC5F-8107-42A8-9106-840BE4E40D0BQ37588412-56E466B8-6ED2-4631-A25E-D57CD65B843CQ38309222-F7BBD6F7-DCE0-4AD8-B8FB-70DBFB5512AFQ38617525-3AD767C7-116F-4502-AD90-D8B74B4A63C8Q39022829-B1339FE0-18D0-43CC-97BF-9F0B07592D2EQ40138726-8EF1DAE7-B738-445C-A435-8C7F730D7782Q40595775-40B9A925-884E-4395-8EEB-5F6B9E147FA4Q41874438-07AC4B45-9049-4A9A-AE9A-35C8A9A2D174Q51514876-BDB12029-0669-4332-895B-24506CDB4E12Q52899497-C95621C6-6816-49DD-8C06-F8B71AF8F2AAQ55166882-96161E0F-8789-4972-ADD7-642183504602Q55318081-3B82CA23-5356-4532-BE21-DF14E4EE9E0CQ55880215-C8A4749F-8451-4193-B089-1C330F409D06
P2860
Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A.
@en
Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A.
@nl
type
label
Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A.
@en
Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A.
@nl
prefLabel
Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A.
@en
Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A.
@nl
P2093
P2860
P50
P356
P1476
Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A
@en
P2093
Ashley B Cardamone
DeLisa Fairweather
Djahida Bedja
Dongfeng Zheng
G Christian Baldeviano
Jobert G Barin
Kathleen L Gabrielson
Monica V Talor
Noel R Rose
P2860
P304
P356
10.4049/JIMMUNOL.1301282
P407
P577
2013-09-18T00:00:00Z